Table 1.
Included population’s general data, SOFA score, SAPS II score and comorbidities. Detailed patient characteristics are available in supplementary table 1 in the electronic supplementary material
Population | n = 18 | ||
Age (years) | 63.6 ± 11.6 | ||
Sex | 14 M (77.8%); 4 F (22.2%) | ||
BMI | 28.0 ± 5.2 | ||
Length of stay (days) | 14.9 ± 9.1 | ||
SOFA Score | 12.8 ± 3.1 | ||
SAPS II - Score in points | 41.8 ± 11.1 | ||
SAPS II - Score in % predicted mortality | 31.8 ± 19,5% | ||
Comorbidities | CIP/CIM | Normal | Died |
COPD (n = 4) | 4 (100%) | - | - |
Cancer (n = 5) | 5 (100%) | - | 3 (60%) |
Diabetes (n = 5) | 3 (60%) | 2 (40%) | - |
AKI KDIGO ≥ 1 (n = 14) | 13 (92.9%) | 1 (7.1%) | 3 (21.4%) |
AKI KDIGO ≥ 3 (n = 9) | 8 (88.9%) | 1 (1.1%) | 2 (2.2%) |
Overall | 16 (88.9%) | 2 (1.1%) | 4 (2.2%) |